ImmuneResearch Phase

Beta-Defensin 3

Topical, Subcutaneous injection

Overview

Beta-defensin 3 (hBD-3) is an antimicrobial peptide of approximately 45 amino acids with potent activity against a wide range of pathogens, including antibiotic-resistant strains. It acts by permeabilizing microbial membranes and modulating host immune responses.

Mechanism of Action

Therapeutic applications include topical antimicrobial therapy and vaccine adjuvants..

Research Summary & Key Findings

In vitro and animal studies have demonstrated hBD-3 efficacy against methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Candida species. Translation to clinical use has been limited by challenges in large-scale synthesis and formulation stability, with no approved products to date.

Clinical Status

Research Phase

Beta-Defensin 3 is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

TopicalSubcutaneous injection

Related Peptides in Immune

Find a Provider

Find a verified provider who offers Beta-Defensin 3 therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Beta-Defensin 3.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.